Tersan Pharmaceuticals Ltd and Laboratoires Pierre Fabre have recently published the results of a clinical data mining study using KEM to identify the best responder subgroups for Milnacipran in fibromyalgia.
“Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables”, Lilia Abtroun, PhD, Pierre Bunouf, PhD, Roger M Gendreau, MD, PhD and Olivier Vitton, MD, Clin. J. Pain, 32 (2016) 435–440